Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
March 5, 2012
DATA PRESENTED AT THE 2012 EUROPEAN CONGRESS OF PSYCHIATRY SHOWING THAT SELINCRO(TM) REDUCES TOTAL ALCOHOL CONSUMPTION BY TWO-THIRDS ON AVERAGE AFTER SIX MONTHS OF TREATMENT
March 1, 2012
BIOTIE SUCCESSFULLY COMPLETES IMAGING STUDY WITH SYN120
December 14, 2011
CLINICAL NEUROSCIENTIST, WILLIAM Z. POTTER, M.D., PH.D., JOINS ENVOY’S ADVISORY BOARD
December 7, 2011
PEARL THERAPEUTICS REPORTS POSITIVE PHASE 2B RESULTS OF PT001 IN PATIENTS WITH COPD
December 5, 2011
DVS SCIENCES APPOINTS JOSEPH VICTOR AS PRESIDENT AND CEO
October 11, 2011
CLEAVE BIOSCIENCES RAISES $42 MILLION IN SERIES A FINANCING FOR NOVEL CANCER THERAPIES
September 28, 2011
ACHAOGEN APPOINTS CHIEF MEDICAL OFFICER KENNETH HILLAN TO CHIEF EXECUTIVE OFFICER
September 22, 2011
BRISTOL-MYERS SQUIBB AND AMBRX ANNOUNCE COLLABORATION FOR NOVEL BIOLOGICS PROGRAMS IN DIABETES AND HEART FAILURE
September 6, 2011
FIERCEBIOTECH NAMES PEARL THERAPEUTICS A 2011 FIERCE 15 BIOTECH
August 31, 2011
ENVOY GARNERS FLORIDA GOVERNOR’S 2011 BUSINESS DIVERSIFICATION AWARD
« Previous Page
1
…
109
110
111
112
113
…
119
Next Page »